DiscoverMinimally ViableMinimally Viable E26- Jannick Bendtsen, PipeBio Co-founder and CEO on doing YC as a biotech founder and the intersection of tech and biotech
Minimally Viable E26- Jannick Bendtsen, PipeBio Co-founder and CEO on doing YC as a biotech founder and the intersection of tech and biotech

Minimally Viable E26- Jannick Bendtsen, PipeBio Co-founder and CEO on doing YC as a biotech founder and the intersection of tech and biotech

Update: 2021-12-16
Share

Description

In today’s episode of Minimally Viable, we talk to Jannick Bendtsen, Co-Founder, and CEO of PipeBio. PipeBio is an innovative biotech cloud-based platform that enables faster development for antibody/peptide screening and drug development and allows scientists to analyze large sets of data. Jannick shares his journey from earning a master’s in molecular biology and a Ph.D. in bioinformatics, to leaving academia and working for bioinformatics companies, to meeting his co-founder Owen and founding PipeBio during the pandemic. We talk about his previous experience and how he worked at three companies that were acquired and how experiencing that process helped him when founding PipeBio. We discuss the importance of the relationship with your cofounder and finding people who complement your skills. We also talk about the importance of trust amongst first hires for an early-stage remote-only start-up. He shares his experience of going through YC and the value of it, especially for early-stage startups, and the network developed during that experience. We talk about the goals for PipeBio and new trends emerging in biotech.
(https://pipebio.com/)
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Minimally Viable E26- Jannick Bendtsen, PipeBio Co-founder and CEO on doing YC as a biotech founder and the intersection of tech and biotech

Minimally Viable E26- Jannick Bendtsen, PipeBio Co-founder and CEO on doing YC as a biotech founder and the intersection of tech and biotech

Jonathan Graeupner and Kevin Burton